Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists
Author:
Affiliation:
1. School of Pharmacy; The Chinese University of Hong Kong; Hong Kong
2. Department of Medicine and Therapeutics; Faculty of Medicine; The Chinese University of Hong Kong; Hong Kong
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12367/fullpdf
Reference59 articles.
1. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies;Amiri-Kordestani;Drug Resist Updat,2012
2. Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium;Aust;Lab Invest,2004
3. Pleiotropic effects of telmisartan: still more to come?;Benndorf;J Hypertens,2008
4. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity;Benson;Hypertension,2004
5. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells;Bleau;Cell Stem Cell,2009
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An in-depth examination of Per- and Polyfluoroalkyl (PFAS) effects on transporters, with emphasis on the ABC superfamily: A critical review;Toxicology;2024-11
2. ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?;Biomedicines;2024-01-05
3. Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis;Gut;2023-09-28
4. A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies;International Journal of Molecular Sciences;2023-07-07
5. Protein Kinases and Cross-talk between Post-translational Modifications in the Regulation of Drug Transporters;Molecular Pharmacology;2022-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3